Search research articles
Contact Us
Filters
Showing results (91-100 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
April 24, 2014
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection
Peter W Hunt, Elizabeth Sinclair, Benigno Rodriguez, et al.
The Journal of Infectious Diseases
|
October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overview
Michael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Frontiers in Immunology
|
August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV
Michael L Freeman, Brian M Clagett, Daniela Moisi, et al.
Antimicrobial Agents and Chemotherapy
|
June 2, 2011
Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy
Jan Weber, Ana C Vazquez, Dane Winner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 14, 2014
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy
Chad J Achenbach, Ashley L Buchanan, Stephen R Cole, et al.
Journal of the National Cancer Institute
|
July 30, 2013
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
Satish Gopal, Monita R Patel, Elizabeth L Yanik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2014
Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort
Satish Gopal, Monita R Patel, Chad J Achenbach, et al.
The Journal of Infectious Diseases
|
June 16, 2011
Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success
Rajeev K Mehlotra, Vinay K Cheruvu, Melinda J Blood Zikursh, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease
Carey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2013
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
Elizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
April 24, 2014
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection
Peter W Hunt, Elizabeth Sinclair, Benigno Rodriguez, et al.
The Journal of Infectious Diseases
|
October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overview
Michael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Frontiers in Immunology
|
August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV
Michael L Freeman, Brian M Clagett, Daniela Moisi, et al.
Antimicrobial Agents and Chemotherapy
|
June 2, 2011
Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy
Jan Weber, Ana C Vazquez, Dane Winner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 14, 2014
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy
Chad J Achenbach, Ashley L Buchanan, Stephen R Cole, et al.
Journal of the National Cancer Institute
|
July 30, 2013
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
Satish Gopal, Monita R Patel, Elizabeth L Yanik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2014
Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort
Satish Gopal, Monita R Patel, Chad J Achenbach, et al.
The Journal of Infectious Diseases
|
June 16, 2011
Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success
Rajeev K Mehlotra, Vinay K Cheruvu, Melinda J Blood Zikursh, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease
Carey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2013
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
Elizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
Page
of 14